NASDAQ:VIH

VPC Impact Acquisition (VIH) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$0.33
$0.38
50-Day Range
$8.03
$36.23
52-Week Range
$9.07
$22.56
Volume
5.82 million shs
Average Volume
1.05 million shs
Market Capitalization
$9.33 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
VIH stock logo

About VPC Impact Acquisition Stock (NASDAQ:VIH)

VPC Impact Acquisition Holdings is a blank check company. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. The company was incorporated in 2020 and is based headquartered in Chicago, Illinois.

VIH Stock News Headlines

Focus Impact Acquisition Corp (FIAC)
DevvStream Reaches Key Milestone Toward Nasdaq Listing
The #1 Biotech Stock to Have on Your Radar in 2024…
Revenues exploding, a $18.70 price target, and highly lucrative addressable markets make this one you cannot ignore!
The #1 Biotech Stock to Have on Your Radar in 2024…
Revenues exploding, a $18.70 price target, and highly lucrative addressable markets make this one you cannot ignore!
BKKT Bakkt Holdings, Inc.
See More Headlines
Receive VIH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for VPC Impact Acquisition and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Prepackaged Software
Sub-Industry
N/A
Current Symbol
NASDAQ:VIH
Phone
N/A
Fax
N/A
Employees
3
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$0.79 per share

Miscellaneous

Free Float
N/A
Market Cap
$10.39 million
Optionable
No Data
Beta
N/A
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Key Executives

  • Mr. John G. Martin (Age 61)
    Chairman & CEO
  • Mr. Gordon Watson (Age 42)
    Pres, COO & Director
  • Ms. Olibia Stamatoglou (Age 41)
    Chief Financial Officer

This page (NASDAQ:VIH) was last updated on 4/24/2024 by MarketBeat.com Staff

From Our Partners